Upregulated RUNX1 inhibits the invasiveness of most breast cancer subtypes, especially in the early stages of tumorigenesis, and prevents the epithelial–mesenchymal transition in breast cancer cells [32]. Here, RUNX1 is linked to breast carcinoma.